Las legislaturas publican los títulos, el historial y el texto oficial de los proyectos de ley en inglés, y los resúmenes provienen de fuentes en inglés, por eso aquí aparecen en inglés.
H.R. 3029119.º Congreso
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
Avance
- Presentado
- En comité
- Aprobado por la Cámara
- Aprobado por el Congreso Todavía no
- Enviado al presidente Todavía no
- Se convirtió en ley Todavía no
En lenguaje sencillo
Nucleic Acid Standards for Biosecurity Act
This bill explicitly requires the National Institute of Standards and Technology (NIST) to support the development of best practices and technical standards for nucleic acid synthesis.
Nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), carry genetic information within cells. Nucleic acid synthesis is the process of designing and creating custom nucleic acids; it is used in the development of medications and agricultural products. However, this technology also poses a risk of misuse (e.g., the intentional or unintentional creation of dangerous biological agents).
The bill requires NIST to carry out measurement research to support the development and improvement of biosecurity best practices and technical standards related to nucleic acid synthesis. This effort must address specified topics including nucleic acid synthesis screening, operational security, and conformity assessment. (A 2023 executive order titled Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence directed NIST to develop and refine similar specifications and best practices for use by synthetic nucleic acid providers. NIST's work on this topic is ongoing.)
In carrying out this effort, NIST must convene stakeholders to develop and periodically update consensus priorities and best practices for synthetic nucleic acid screening mechanisms. Within a specified period, NIST must submit a summary of the stakeholder group’s findings to Congress.
NIST must also take steps to advance risk management best practices and technical standards for engineering biology and biomanufacturing, including with respect to risks associated with the use of artificial intelligence.
Resumen del Servicio de Investigación del Congreso (CRS), una oficina no partidista de la Biblioteca del Congreso. Versión resumida: Introduced in House.
Lo que costaría este proyecto
-
H.R. 3029, Nucleic Acid Standards for Biosecurity Act
As ordered reported by the House Committee on Science, Space, and Technology on April 29, 2025
Las estimaciones provienen de la Oficina de Presupuesto del Congreso (CBO) y reflejan el proyecto tal como estaba redactado en ese momento.
Historial legislativo
-
Senado
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
-
Cámara de Representantes
Motion to reconsider laid on the table Agreed to without objection.
-
Cámara de Representantes
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)
-
Cámara de Representantes
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)
-
Cámara de Representantes
DEBATE - The House proceeded with forty minutes of debate on H.R. 3029.
-
Cámara de Representantes
Considered under suspension of the rules. (consideration: CR H4666-4667)
-
Cámara de Representantes
Mr. Babin moved to suspend the rules and pass the bill, as amended.
-
Cámara de Representantes
Placed on the Union Calendar, Calendar No. 654.
-
Reported by the Committee on Science, Space, and Technology. H. Rept. 119-751.
-
Cámara de Representantes
Ordered to be Reported by Voice Vote.
-
Cámara de Representantes
Committee Consideration and Mark-up Session Held
-
Cámara de Representantes
Referred to the House Committee on Science, Space, and Technology.
-
Introduced in House